Patents
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
12/2006
12/14/2006US20060281087 Titanium dioxide complex having molecule distinguishability
12/13/2006EP1731500A1 5-aminolevulinic acid salt, process for producing the same and use thereof
12/13/2006EP1731162A2 Apparatus, method and compositions for the treatment of cancers by ultraphoresis
12/13/2006EP1482975B1 Prevention of tissue adhesion
12/13/2006CN1879065A Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents
12/13/2006CN1875986A Method for extended storage of blood and blood components
12/13/2006CN1289150C Method of inactivating microorganisms in a fluid using ultraviolet radiation
12/12/2006US7147860 Botanical and non-botanical ingredients for symptomatic relief of sexually transmitted diseases and other urogenital disorders
12/12/2006US7147850 Therapeutic binding agents against MUC-1 antigen and methods for their use
12/07/2006WO2006130826A1 Method for terminal sterilization of transdermal delivery devices
12/07/2006WO2006129080A1 Materials and methods for transducing cells with a viral vector
12/07/2006WO2004071435A3 Enhanced Bioavailability Using Laser Resonant Homogenization
12/07/2006US20060275750 Bioreactive agents
12/07/2006CA2610245A1 Method for terminal sterilization of transdermal delivery devices
12/06/2006EP1728519A2 Polar supporting and broad-band resonant preparation
12/06/2006EP1631146A4 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
12/06/2006EP1590038A4 Light probe for ultraviolet light activated gene transduction
12/06/2006EP1137411B1 Palladium-substituted bacteriochlorophyll derivatives and use thereof
12/06/2006CN1874789A Conjugates for photodynamic therapy
12/06/2006CN1874781A Compositions of botanical extracts for cancer therapy
12/06/2006CN1287859C Magnetic targeted carrier composed of iron and porous materials for targeted delivery of biologically active agents
12/05/2006US7144879 Substituted metal-phthalocyanines, their preparation and the use thereof
12/05/2006US7144627 Multi-layer nanoshells comprising a metallic or conducting shell
12/05/2006CA2218860C Apparatus and method for making gas-filled vesicles of optimal size
11/2006
11/30/2006WO2006126244A1 Method of producing liposomes containing gas enclosed therein
11/30/2006WO2006125452A1 Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
11/30/2006US20060270967 Synergism of photodynamic and electropermeation effects on cell vitality as a novel cytotoxic agent
11/30/2006CA2609373A1 Method of producing liposomes containing gas enclosed therein
11/29/2006EP1726312A1 Improvements in nutritional value and enhanced agricultural yield by spectral or electromagnetic energy irradiation
11/28/2006US7141233 Radionuclide labeling of vitamin B12 and coenzymes thereof
11/28/2006CA2259509C Method and device for treating a liquid medium
11/23/2006US20060264520 Surface-modified titanium dioxide fine particles and dispersion comprising the same, and method for producing the same
11/23/2006US20060263392 Method for treating neovascularization
11/22/2006EP1723431A1 Hybrid nanoparticles including an ln2o3 core and having bioligands, and method for preparing same
11/22/2006EP1722818A2 Photoreactive compound specifically binding to calcium binding proteins
11/22/2006EP1459738A4 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties
11/22/2006EP1381571B1 Antioxidants in clusters of structured water
11/22/2006EP1361899B1 Silicon implants comprising a radionucleotide for use in brachytherapy
11/22/2006EP0935415B1 In vitro methods for delivering nucleic acids into a cell
11/22/2006CN1867357A Conjugate of a photosensitiser and a bacteriophage
11/21/2006US7138381 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/2006CA2247611C Method and composition for hair removal
11/21/2006CA2243392C Use of a texaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization
11/16/2006US20060258635 Use of a porphyrin compound for the treatment of skin fungi
11/16/2006US20060258629 Photodynamic therapy for ocular neovascularization
11/16/2006US20060257319 Method for in vivo determination on tested animals of the efficient concentration of deuterium depleted water for cancer therapy
11/16/2006US20060257315 Activation and production of radiolabeled particles
11/15/2006EP1720612A2 Cancer treatment with topoisomerase-ii inhibitor, a bis-dioxypiperazine and radiation
11/15/2006EP1720609A1 Photodynamic therapy for the treatment of prostatic conditions
11/15/2006EP1720576A1 Photodynamic therapy for the treatment of acne
11/14/2006US7135496 Antitumor, anticancer agents; rheumatic diseases; autoimmune diseases
11/14/2006US7135193 Liposome compositions of porphyrin photosensitizers
11/14/2006US7135162 Agent for diagnosing and treating malignant tumors
11/14/2006US7135033 Phototreatment device for use with coolants and topical substances
11/09/2006WO2006119284A2 Conjugated aromatic compounds for diagnosis and therapy
11/09/2006WO2006119211A2 Methods and compositions for treating ocular disorders
11/09/2006WO2006117399A1 Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use
11/09/2006US20060252766 Methods using a combination of 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/09/2006US20060252674 Methods for pretreating a subject with extracorporeal photopheresis
11/09/2006US20060251734 enhancing cancer cell death using therapeutically effective amounts of DNA damaging agent(s) that act in combination to enhance cancer cell death, e.g., nucleic acid precursors, and protein tyrosine kinase inhibitors, e.g., that inhibit EGFR activity; pancreatic cancer treatment
11/09/2006US20060251712 Method and composition for hyperthermally treating cells
11/09/2006CA2607572A1 Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use
11/09/2006CA2606599A1 Conjugated aromatic compounds for diagnosis and therapy
11/08/2006CN1859947A Phototherapeutic treatment of skin conditions
11/08/2006CN1283255C Magnetic slow release 5-aminosalicylic acid with intercalate structure and its preparation method
11/07/2006CA2416879C Methods of treating cancer and the pain associated therewith using endothelin antagonists
11/02/2006WO2006115273A1 Method for treating body fluid
11/02/2006EP1467761B1 Treatment of neovascular ophthalmic disease
11/02/2006EP1229867B1 Ophthalmologic implant
11/02/2006EP1217981B1 Container for electrically preparing injectable fluids
10/2006
10/31/2006US7128896 using carbocyanine dyes; photodynamic therapy; in vivo supplying to tumor
10/26/2006WO2006112379A1 Drug for treating or diagnosing vascular lesion in the skin or the subcutaneous soft tissue caused by light irradiation
10/26/2006US20060241466 Hollow microspheres with controlled fragility for medical use
10/26/2006US20060241166 Sapphyrins and uses thereof
10/26/2006US20060240088 Caged ligands and uses thereof
10/26/2006US20060237025 Method of reducing the harmful effects of orally or transdermally delivered nicotine
10/26/2006CA2605617A1 Photodynamic therapy using chemiluminescence and a ligand-photosensitiser conjugate
10/25/2006EP1309283A4 Accurate optical treatment of an eye's fundus
10/24/2006US7125542 Methods and compositions for treating conditions of the eye
10/19/2006WO2006035204A3 Combination comprising zd6474 and an imatinib
10/19/2006WO2005102367A3 Coadministration of radiation, efaproxiral sodium, and supplemental oxygen for the treatment of cancer
10/19/2006US20060231107 Antibody-targeted photodynamic therapy
10/19/2006DE102005016873A1 New nano-particle useful for production of composition to treatment and/or prophylaxis of proliferative illnesses, cancer and bacterial infections, where nano-particle is bonded therapeutic substance
10/18/2006CN1279907C Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
10/17/2006USRE39357 Medicine for clogging blood vessels of eye fundus
10/17/2006US7122569 Treatment of tumors by irradiating with light after administration of protoporphyrin derivative; ethylene glycol esters of monohydrobenzoporphyrins
10/17/2006US7122518 Administering a quenching photosensitizer molecule for side effect reduction to retinal pigmented epithelium; age related macular degeneration
10/17/2006US7122208 Administering aliquot of blood which has been treated ex vivo with stressors such as oxidation, thermal stress and electromagnetic radiation; wherein concentration of reactive oxygen species in neuronal cells or tissues is reduced
10/17/2006CA2087902C Liposome compositions of porphyrin photosensitizers
10/12/2006WO2006107598A2 Conjugates of photoactive compound and a bulking group for enhancing photodynamic therapy
10/12/2006WO2006106984A1 Potentiator for radiation therapy comprising pyridine derivative as active ingredient
10/12/2006WO2006106383A1 Photosensitizers and mri enhancers
10/12/2006WO2006063418A3 Nanostructure radioactif
10/12/2006CA2603524A1 Photosensitizers and mri enhancers
10/11/2006EP1709973A1 Method of suppressing cancer
10/10/2006US7119069 Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent
10/10/2006US7118524 Dosimetry for californium-252 (252Cf) neutron-emitting brachytherapy sources and encapsulation, storage, and clinical delivery thereof
10/10/2006CA2268968C Iminochlorin aspartic acid derivatives
10/05/2006WO2006105507A2 Indoloquinone tumor radiation sensitization
10/05/2006US20060223880 Methods of protecting against radiation injury
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 95